Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -54.29% is 32% below its 5-year average of -41.22%, around the middle of its 5-year range (-107.44%–35.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.24% below its 12-month average of -36.38%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.29%.
RETURN ON EQUITY (ROE)
-54.29%
RETURN ON EQUITY (ROE) AVG TTM
-36.38%
RETURN ON EQUITY (ROE) AVG 3Y
-29.34%
RETURN ON EQUITY (ROE) AVG 5Y
-41.22%
RETURN ON EQUITY (ROE) AVG 10Y
-41.89%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-49.24%
CURRENT VS 3Y AVG
-85.02%
CURRENT VS 5Y AVG
-31.72%
CURRENT VS 10Y AVG
-29.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 623 covered companies
CURRENT VS SECTOR MEDIAN
-35.05%
vs the sector median at left
Arcturus Therapeutics Holdings Inc.
Market Cap
$376.04M
Return on Equity (ROE)
-54.29%
TTM Avg
-36.38%
3Y Avg
-29.34%
5Y Avg
-41.22%
Market Cap
$374.87M
Return on Equity (ROE)
-38.57%
TTM Avg
-80.22%
3Y Avg
-181.01%
5Y Avg
-130.47%
Market Cap
$384.56M
Return on Equity (ROE)
-14.38%
TTM Avg
-22.77%
3Y Avg
-19.17%
5Y Avg
-14.56%
Market Cap
$384.83M
Return on Equity (ROE)
-92.20%
TTM Avg
-58.64%
3Y Avg
-50.24%
5Y Avg
-28.80%
Market Cap
$364.53M
Return on Equity (ROE)
N/A
TTM Avg
-589.37%
3Y Avg
-290.01%
5Y Avg
-205.39%
Market Cap
$362.81M
Return on Equity (ROE)
N/A
TTM Avg
187.63%
3Y Avg
25.60%
5Y Avg
-9.96%
Market Cap
$356.58M
Return on Equity (ROE)
-7.66%
TTM Avg
-10.18%
3Y Avg
260.20%
5Y Avg
144.75%
Market Cap
$357.28M
Return on Equity (ROE)
N/A
TTM Avg
-12.63%
3Y Avg
-14.73%
5Y Avg
14.28%
Market Cap
$355.18M
Return on Equity (ROE)
-62.56%
TTM Avg
-108.31%
3Y Avg
-79.06%
5Y Avg
-57.33%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $376.04M | -54.29% | -36.38% | -29.34% | -41.22% |
| Canopy Growth Corporation (CGC)vs › | $374.87M | -38.57% | -80.22% | -181.01% | -130.47% |
| Orthofix Medical Inc. (OFIX)vs › | $384.56M | -14.38% | -22.77% | -19.17% | -14.56% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.83M | -92.20% | -58.64% | -50.24% | -28.80% |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | N/A | -589.37% | -290.01% | -205.39% |
| Ocugen, Inc. (OCGN)vs › | $362.81M | N/A | 187.63% | 25.60% | -9.96% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.58M | -7.66% | -10.18% | 260.20% | 144.75% |
| Embecta Corp. (EMBC)vs › | $357.28M | N/A | -12.63% | -14.73% | 14.28% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $355.18M | -62.56% | -108.31% | -79.06% | -57.33% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.92M | -26.14% | -53.80% | -12.25% | 19.21% |
ROE
-54.3%
ROA
-41.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -54.29% |
| 2026-03-31 | -41.11% |
| 2025-12-31 | -30.74% |
| 2025-09-30 | -29.71% |
| 2025-06-30 | -26.04% |
| 2025-03-31 | -29.18% |
| 2024-12-31 | -33.59% |
| 2024-09-30 | -23.92% |
| 2024-06-30 | -27.83% |
| 2024-03-31 | -40.65% |
| 2023-12-31 | -10.67% |
| 2023-09-30 | 35.47% |
| 2023-06-30 | 28.15% |
| 2023-03-31 | 33.80% |
| 2022-12-31 | 3.46% |
| 2022-09-30 | -100.68% |
| 2022-06-30 | -96.93% |
| 2022-03-31 | -107.44% |
| 2021-12-31 | -89.25% |
| 2021-09-30 | -75.68% |
| 2021-06-30 | -53.34% |
| 2021-03-31 | -33.67% |
| 2020-12-31 | -18.19% |
| 2020-09-30 | -19.89% |
| 2020-06-30 | -41.17% |
| 2020-03-31 | -170.09% |
| 2019-12-31 | -100.77% |
| 2019-09-30 | -44.61% |
| 2019-06-30 | -59.36% |
| 2019-03-31 | -347.78% |
| 2018-12-31 | -159.69% |
| 2018-09-30 | -154.83% |
| 2018-06-30 | -113.58% |
| 2018-03-31 | -41.29% |
| 2017-12-31 | -32.26% |
| 2017-09-30 | -40.98% |
| 2017-06-30 | -51.46% |
| 2017-03-31 | -52.09% |
| 2016-12-31 | -52.09% |
| 2016-09-30 | -44.78% |
| 2016-06-30 | -33.49% |
| 2016-03-31 | -29.79% |
| 2015-12-31 | -28.05% |
| 2015-09-30 | -60.90% |
| 2015-06-30 | -71.18% |
| 2014-12-31 | -164.64% |
| 2014-09-30 | -122.26% |
| 2014-06-30 | -68.83% |
| 2014-03-31 | -42.45% |
| 2013-12-31 | -21.66% |
| 2013-09-30 | -27.74% |
| 2013-06-30 | -10.74% |
